Impact of Implementing CYP2C19 Genotype-Guided Antiplatelet Therapy on P2Y12 Inhibitor Selection and Clinical Outcomes in Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention: A Real-World Study in China

• Asıl Yazarlar: Yi Zhang (Yazar), Xiu-Jin Shi (Yazar), Wen-Xing Peng (Yazar), Jia-Lun Han (Yazar), Bai-Di Lin (Yazar), Ru Zhang (Yazar), Yun-Nan Zhang (Yazar), Jia-Lin Yan (Yazar), Juan-Juan Wei (Yazar), Yi-Fan Wang (Yazar), Su-Wei Chen (Yazar), Nan Nan (Yazar), Zhen-Wei Fang (Yazar), Yong Zeng (Yazar), Yang Lin (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2021-01-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background: CYP2C19 loss-of-function (LOF) alleles reduce the effectiveness of clopidogrel in patients undergoing percutaneous coronary intervention for acute coronary syndrome. However, the clinical impact of implementing CYP2C19 gene-guided pharmacotherapy is unclear, especially among the Chinese...